VANDA PHARMACEUTICALS INC. (VNDA) Operating income 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) annual operating income history from SEC filings — each fiscal year as reported.
-$151.2MFY2025 · since FY2016: -$18.6M → -$151.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$151.2M | -271.8% |
| FY2024 | -$40.7M | -191.4% |
| FY2023 | -$14.0M | -320.4% |
| FY2022 | $6.3M | -85.0% |
| FY2021 | $42.2M | +54.8% |
| FY2020 | $27.2M | +19.4% |
| FY2019 | $22.8M | +4.9% |
| FY2018 | $21.7M | +228.6% |
| FY2017 | -$16.9M | +9.0% |
| FY2016 | -$18.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VNDA financial trends
VNDA RevenueVNDA Net incomeVNDA Net marginVNDA Gross profitVNDA Gross marginVNDA Operating marginVNDA Operating cash flowVNDA Free cash flowVNDA Capital expendituresVNDA Return on equityVNDA Stock buybacksVNDA Dividends paidVNDA Total assetsVNDA Total liabilitiesVNDA Shareholders’ equityVNDA overview →